share_log

多瑞医药:独立董事2023年度述职报告(刘颖斐)

Dorui Pharmaceuticals: Independent Director's 2023 Debriefing Report (Liu Yingfei)

深证信a股 ·  Apr 17
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more